ZVRA · Company research
Zevra Therapeutics, Inc. (ZVRA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
12records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A 20,000-share sale was reported by Zevra Therapeutics (ZVRA) director Neil F. McFarlane. - Stock Titan | A 20,000-share sale was reported by Zevra Therapeutics (ZVRA) director Neil F. McFarlane. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| ZVRA Stock Hits Its Highest Levels In Nearly 5 Years – What’s Driving This Sharp Rally Today? - Stocktwits | ZVRA Stock Hits Its Highest Levels In Nearly 5 Years – What’s Driving This Sharp Rally Today? Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Zevra Therapeutics (NasdaqGS:ZVRA) Stock Forecast & Analyst Predictions - Simply Wall Street | Zevra Therapeutics (NasdaqGS:ZVRA) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 30, 2026 | neutral | 0 | 0.6 |
| Zevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance | Zevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 5, 2026 | neutral | 0 | 0.6 |
| Zevra Therapeutics (ZVRA) Releases Q2 2026 Earnings: Revenue Growth and EPS Beat | ZVRA Stock News - Quiver Quantitative | Zevra Therapeutics (ZVRA) Releases Q2 2026 Earnings: Revenue Growth and EPS Beat | ZVRA Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 5, 2026 | neutral | 0 | 0.6 |
| Zevra Therapeutics (ZVRA) Securities Investigation Notice - Levi & Korsinsky - PR Newswire | Zevra Therapeutics (ZVRA) Securities Investigation Notice - Levi & Korsinsky PR Newswire | View source ↗ | PR Newswire | Aug 3, 2026 | neutral | 0 | 0.6 |
| ZVRA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zevra Therapeutics - Morningstar | ZVRA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zevra Therapeutics Morningstar | View source ↗ | Morningstar | Jul 28, 2026 | neutral | 0 | 0.6 |
| Zevra Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Zevra Therapeutics (ZVRA) - PR Newswire | Zevra Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Zevra Therapeutics (ZVRA) PR Newswire | View source ↗ | PR Newswire | Jul 27, 2026 | neutral | 0 | 0.6 |
| ZVRA Stock Sinks 23% On EU Setback — Analyst Says Risk Is ‘A Headwind, But Not Insurmountable’ - Stocktwits | ZVRA Stock Sinks 23% On EU Setback — Analyst Says Risk Is ‘A Headwind, But Not Insurmountable’ Stocktwits | View source ↗ | Stocktwits | Jul 24, 2026 | neutral | 0 | 0.6 |
| ZVRA Stock Slides As Traders Gauge Pullback And Cash Strength - StocksToTrade | ZVRA Stock Slides As Traders Gauge Pullback And Cash Strength StocksToTrade | View source ↗ | StocksToTrade | Jul 24, 2026 | neutral | 0 | 0.6 |
| ZVRA Stock Sinks 23% On EU Setback — Analyst Says Risk Is ‘A Headwind, But Not Insurmountable’ - TradingView | ZVRA Stock Sinks 23% On EU Setback — Analyst Says Risk Is ‘A Headwind, But Not Insurmountable’ TradingView | View source ↗ | TradingView | Jul 24, 2026 | neutral | 0 | 0.6 |
| Is It Too Late To Consider Zevra Therapeutics (ZVRA) After The Recent Share Price Surge? - Yahoo Finance | Is It Too Late To Consider Zevra Therapeutics (ZVRA) After The Recent Share Price Surge? Yahoo Finance | View source ↗ | Yahoo Finance | May 7, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.